These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

406 related articles for article (PubMed ID: 17343223)

  • 21. Pure neural leprosy: diagnostic value of the polymerase chain reaction.
    Bezerra Da Cunha FM; Werneck MC; Scola RH; Werneck LC
    Muscle Nerve; 2006 Mar; 33(3):409-14. PubMed ID: 16315323
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Facial tuberculoid leprosy: case report.
    Ali K; Sittampalam G; Malik MA
    Br J Oral Maxillofac Surg; 2011 Jan; 49(1):70-2. PubMed ID: 20188445
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Are viable Mycobacterium leprae present in lepromatous patients after completion of 12 months' and 24 months' multi-drug therapy?
    Ebenezer GJ; Daniel S; Norman G; Daniel E; Job CK
    Indian J Lepr; 2004; 76(3):199-206. PubMed ID: 15835604
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Multiplication of mycobacterium leprae in nude mice].
    Wang HY
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1989 Oct; 11(5):358-62. PubMed ID: 2534616
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Detection of AFB in tuberculoid biopsies.
    Fleury RN; Aranda CM
    Int J Lepr Other Mycobact Dis; 1995 Mar; 63(1):103. PubMed ID: 7730706
    [No Abstract]   [Full Text] [Related]  

  • 26. Borderline tuberculoid leprosy localised over a scar.
    Kar BK; Job CK
    Indian J Lepr; 2005; 77(2):173-6. PubMed ID: 16044818
    [No Abstract]   [Full Text] [Related]  

  • 27. Susceptibility of severe combined immunodeficient mice to Mycobacterium leprae.
    Ishaque M; Sticht-Groh V; Togola D
    Microbios; 1996; 88(354):19-26. PubMed ID: 9121376
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Leprosy in five human immunodeficiency virus-infected patients.
    Moran CA; Nelson AM; Tuur SM; Luengu M; Fonseca L; Meyers WM
    Mod Pathol; 1995 Aug; 8(6):662-4. PubMed ID: 8532702
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Correlation viability/morphology in Mycobacterium leprae.
    Silva MT; Macedo PM; Portaels F; Pattyn SR
    Acta Leprol; 1984; 2(2-4):281-91. PubMed ID: 6398588
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The mouse foot-pad technique for cultivation of Mycobacterium leprae.
    Levy L; Ji B
    Lepr Rev; 2006 Mar; 77(1):5-24. PubMed ID: 16715686
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Treatment of bacilliferous BL/LL cases with combined chemotherapy and immunotherapy.
    Katoch K; Katoch VM; Natrajan M; Bhatia AS; Sreevatsa ; Gupta UD; Sharma VD; Shivannavar CT; Patil MA; Bharadwaj VP
    Int J Lepr Other Mycobact Dis; 1995 Jun; 63(2):202-12. PubMed ID: 7602215
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Nasal mucosa and skin of smear-positive leprosy patients after 24 months of fixed duration MDT: histopathological and microbiological study.
    Ebenezer GJ; Job A; Abraham S; Arunthathi S; Rao PS; Job CK
    Int J Lepr Other Mycobact Dis; 1999 Sep; 67(3):292-7. PubMed ID: 10575409
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Is PGL-1 also present in Leishmania donovani promastigotes?
    Gupta PN; Pal NK
    Indian J Lepr; 1998; 70(2):161-4. PubMed ID: 9724851
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Multibacillary nerve histology in clinically diagnosed borderline tuberculoid leprosy patients.
    Ebenezer GJ; Suneetha S; Mohandas R; Arunthathi S
    Int J Lepr Other Mycobact Dis; 1996 Sep; 64(3):311-5. PubMed ID: 8862266
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Activity of two doses of rifampin against Mycobacterium leprae.
    Husser JA; Traore I; Daumerie D
    Int J Lepr Other Mycobact Dis; 1994 Sep; 62(3):359-64. PubMed ID: 7963907
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The simultaneous inoculation of Mycobacterium leprae and M. intracellulare into nude mice: development of cutaneous leproma and accelleration of foot pad swelling.
    Kazda J; Fasske E; Kolk A; Ganapati R; Schroder KH
    Indian J Lepr; 1987; 59(4):426-34. PubMed ID: 3330554
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Activity of ascorbic acid in inhibiting the multiplication of M. leprae in the mouse foot pad.
    Hastings RC; Richard V; Christy SA; Morales MJ
    Int J Lepr Other Mycobact Dis; 1976; 44(4):427-30. PubMed ID: 798727
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of lyophilization on viability of Mycobacterium leprae multiplied in nude mouse.
    Nakamura M; Kohsaka K
    Acta Leprol; 1989; 7 Suppl 1():36-8. PubMed ID: 2504002
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Detection of viable organisms in leprosy patients treated with multidrug therapy.
    Gupta UD; Katoch K; Singh HB; Natrajan M; Sharma VD; Katoch VM
    Acta Leprol; 1999; 11(3):89-92. PubMed ID: 10544720
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Sciatic nerve of normal and T200x5R Swiss white mice fails to support multiplication of intraneurally injected M. leprae.
    Shetty VP; Matharu PS; Antia NH
    Int J Lepr Other Mycobact Dis; 1999 Dec; 67(4):446-52. PubMed ID: 10700920
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.